Current Clinical Studies
Explore our active clinical trials and find opportunities to participate in advancing medical research.
MIGRA-FREE Trial
A completed pivotal trial that studied a CGRP inhibitor for prevention of chronic migraine. Results showed significant reduction in monthly migraine days with good tolerability.
HEART-RHYTHM Study
An investigational study evaluating a novel antiarrhythmic agent for patients with paroxysmal atrial fibrillation. The study uses continuous cardiac monitoring to assess rhythm control efficacy.
BREATH-EASY COPD Trial
A completed study that evaluated a dual bronchodilator combination inhaler for maintenance treatment of COPD. The study demonstrated significant improvements in lung function and quality of life.
METAB-BALANCE Study
A randomized controlled trial comparing a novel GLP-1 receptor agonist with existing standard of care for glycemic control in patients with type 2 diabetes. Secondary endpoints include weight loss and cardiovascular markers.
ONCO-TARGET Trial
A multi-center study evaluating a targeted therapy for patients with advanced non-small cell lung cancer who have specific genetic markers. This precision medicine approach aims to improve treatment outcomes.
FLU-SHIELD Vaccine Trial
A pivotal study evaluating a next-generation influenza vaccine designed to provide broader protection against multiple flu strains. The study will assess immunogenicity and safety in healthy adults.
NEURO-CLARITY Study
An open-label study investigating a potential treatment for early-stage cognitive decline. Participants will receive the study medication and undergo regular cognitive assessments over the study period.
CARDIO-PREVENT Trial
A randomized, double-blind study evaluating a novel antihypertensive medication for patients with moderate to severe hypertension. This study aims to assess the efficacy and safety of the investigational drug compared to standard treatment.